Kobo Biotech - Quaterly Results

13 Feb 2023 Evaluate
The revenue for the December 2022 quarter is pegged at Rs. 0.00 millions against Rs. 0.00 millions recorded during the year-ago period.The Net Loss for the quarter ended December 2022 is Rs. -11.91 millions as compared to Net Loss of Rs. -13.48 millions of corresponding quarter ended December 2021 Operating profit Margin for the quarter ended December 2022 improved to -1.66% as compared to -3.05% of corresponding quarter ended December 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.15 0.17 -11.76 0.17 0.36 -52.78
PBIDT -1.66 -3.05 -45.57 -6.91 -12.50 -44.72 -104.84 -27.54 280.68
Interest 0.00 0.00 0.00 0.00 1.35 -100.00 1.35 108.41 -98.75
PBDT -1.66 -3.05 -45.57 -6.91 -13.85 -50.11 -106.19 -135.95 -21.89
Depreciation 10.25 10.43 -1.73 30.68 34.24 -10.40 46.06 56.37 -18.29
PBT -11.91 -13.48 -11.65 -37.59 -48.09 -21.83 -152.25 -192.32 -20.84
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -11.91 -13.48 -11.65 -37.59 -48.09 -21.83 -152.25 -192.32 -20.84
Equity 238.25 238.25 0.00 238.25 238.25 0.00 238.25 238.25 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Kobo Biotech Share Price

4.64 -0.07 (-1.49%)
28-May-2024 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1464.85
Dr. Reddys Lab 5955.65
Cipla 1477.15
Zydus Lifesciences 1050.35
Lupin 1603.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.